Goal 2: Reduce Human Disease

Mitigating risks due to the RBC storage lesion and vulnerable patients

What are the underlying dependencies (genomic, metabolic, disease) in individual donors that either accelerate or delay the changes to red blood cells during refrigerated storage? What methods of preparation might protect patients from the risks posed by the accelerated degradation of RBCs provided by "poor storers"? What characteristics of individual patients make them particularly vulnerable to transfusion of red blood cells that have changed during storage? What methods of blood preparation might best protect such patients from the adverse effects of RBC storage?

Tags (Keywords associated with the idea)


3 net votes
3 up votes
0 down votes
Idea No. 1121